315 related articles for article (PubMed ID: 33499388)
1. Targeting the "Sweet Side" of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis.
Bloise N; Okkeh M; Restivo E; Della Pina C; Visai L
Nanomaterials (Basel); 2021 Jan; 11(2):. PubMed ID: 33499388
[TBL] [Abstract][Full Text] [Related]
2. Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet.
Hockl PF; Wolosiuk A; Pérez-Sáez JM; Bordoni AV; Croci DO; Toum-Terrones Y; Soler-Illia GJ; Rabinovich GA
Pharmacol Res; 2016 Jul; 109():45-54. PubMed ID: 26855319
[TBL] [Abstract][Full Text] [Related]
3. Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies.
Marques AC; Costa PJ; Velho S; Amaral MH
J Control Release; 2020 Apr; 320():180-200. PubMed ID: 31978444
[TBL] [Abstract][Full Text] [Related]
4. Exosome-mediated diagnosis of pancreatic cancer using lectin-conjugated nanoparticles bound to selective glycans.
Choi Y; Park U; Koo HJ; Park JS; Lee DH; Kim K; Choi J
Biosens Bioelectron; 2021 Apr; 177():112980. PubMed ID: 33450614
[TBL] [Abstract][Full Text] [Related]
5. Glycans as Targets for Drug Delivery in Cancer.
Diniz F; Coelho P; Duarte HO; Sarmento B; Reis CA; Gomes J
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205658
[TBL] [Abstract][Full Text] [Related]
6. Antibody-targeted biodegradable nanoparticles for cancer therapy.
Shargh VH; Hondermarck H; Liang M
Nanomedicine (Lond); 2016 Jan; 11(1):63-79. PubMed ID: 26654068
[TBL] [Abstract][Full Text] [Related]
7. Altered tumor-cell glycosylation promotes metastasis.
Häuselmann I; Borsig L
Front Oncol; 2014; 4():28. PubMed ID: 24592356
[TBL] [Abstract][Full Text] [Related]
8. Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy.
Wu PH; Opadele AE; Onodera Y; Nam JM
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31766201
[TBL] [Abstract][Full Text] [Related]
9. Lectins as Ligands for Directing Nanostructured Systems.
Devi RV; Basil-Rose MR
Curr Drug Deliv; 2018; 15(4):448-452. PubMed ID: 29308738
[TBL] [Abstract][Full Text] [Related]
10. Aberrant glycosylation patterns on cancer cells: Therapeutic opportunities for glycodendrimers/metallodendrimers oncology.
Moffett S; Shiao TC; Mousavifar L; Mignani S; Roy R
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1659. PubMed ID: 32776710
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnological strategies for therapeutic targeting of tumor vasculature.
Ding Y; Li S; Nie G
Nanomedicine (Lond); 2013 Jul; 8(7):1209-22. PubMed ID: 23837858
[TBL] [Abstract][Full Text] [Related]
12. Overview of Characterizing Cancer Glycans with Lectin-Based Analytical Methods.
Pearson AJ; Gallagher ES
Methods Mol Biol; 2019; 1928():389-408. PubMed ID: 30725466
[TBL] [Abstract][Full Text] [Related]
13. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
Front Oncol; 2016; 6():109. PubMed ID: 27242953
[TBL] [Abstract][Full Text] [Related]
14. Glycan profiling of proteins using lectin binding by Surface Plasmon Resonance.
Wang W; Soriano B; Chen Q
Anal Biochem; 2017 Dec; 538():53-63. PubMed ID: 28947169
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
[TBL] [Abstract][Full Text] [Related]
16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
17. Lectin biosensors in cancer glycan biomarker detection.
Silva MLS
Adv Clin Chem; 2019; 93():1-61. PubMed ID: 31655728
[TBL] [Abstract][Full Text] [Related]
18. Surface glycan targeting for cancer nano-immunotherapy.
Choi Y; Kim J; Chae J; Hong J; Park J; Jeong E; Kim H; Tanaka M; Okochi M; Choi J
J Control Release; 2022 Feb; 342():321-336. PubMed ID: 34998918
[TBL] [Abstract][Full Text] [Related]
19. Rapid On-Chip Synthesis of Complex Glycomimetics from N-Glycan Scaffolds for Improved Lectin Targeting.
Cioce A; Thépaut M; Fieschi F; Reichardt NC
Chemistry; 2020 Oct; 26(56):12809-12817. PubMed ID: 32445493
[TBL] [Abstract][Full Text] [Related]
20. Detection of distinct glycosylation patterns on human γ-glutamyl transpeptidase 1 using antibody-lectin sandwich array (ALSA) technology.
West MB; Partyka K; Feasley CL; Maupin KA; Goppallawa I; West CM; Haab BB; Hanigan MH
BMC Biotechnol; 2014 Dec; 14():101. PubMed ID: 25479762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
